Combination of Chinese Herbal Medicines and Conventional Treatment versus Conventional Treatment Alone in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention (5C Trial): An Open-Label Randomized Controlled, Multicenter Study

Combination of Chinese Herbal Medicines and Conventional Treatment versus Conventional Treatment Alone in Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention (5C Trial): An Open-Label Randomized Controlled, Multicenter Study

Aims. To evaluate the efficacy of Chinese herbal medicines (CHMs) plus conventional treatment in patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI). Methods and Results. Participants (n=808) with ACS who underwent PCI from thirteen hospitals of mainland China...

Full description

Bibliographic Details
Main Authors: Shao-Li Wang, Cheng-Long Wang, Pei-Li Wang, Hao Xu, Hong-Ying Liu, Jian-Peng Du, Da-Wu Zhang, Zhu-Ye Gao, Lei Zhang, Chang-Geng Fu, Shu-Zheng Lü, Shi-Jie You, Jun-Bo Ge, Tian-Chang Li, Xian Wang, Guan-Lin Yang, Hong-Xu Liu, Jing-Yuan Mao, Rui-Jie Li, Li-Dian Chen, Shu Lu, Da-Zhuo Shi, Ke-Ji Chen
Format: Article
Language:English
Published: Hindawi Limited 2013-01-01
Series:Evidence-Based Complementary and Alternative Medicine
Online Access:http://dx.doi.org/10.1155/2013/741518

Internet

http://dx.doi.org/10.1155/2013/741518

Similar Items